Cargando…
ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma
Purpose: To explore the role of ORC6 in clear cell renal cell carcinoma (ccRCC). Methods: The Cancer Genome Atlas Kidney Clear Cell Carcinoma (TCGA-KIRC) database was used to investigate the association between ORC6 expression and clinicopathological parameters. Furthermore, the expression level of...
Autores principales: | Pan, Qiufeng, Li, Fuchun, Ding, Yi, Huang, Haoxuan, Guo, Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174843/ https://www.ncbi.nlm.nih.gov/pubmed/35711825 http://dx.doi.org/10.7150/jca.71313 |
Ejemplares similares
-
TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma
por: Pan, Qiufeng, et al.
Publicado: (2020) -
Overexpression of LINC00160 predicts poor outcome and promotes progression of clear cell renal cell carcinoma
por: Cheng, Gong, et al.
Publicado: (2020) -
Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2019) -
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2019) -
The structure of ORC–Cdc6 on an origin DNA reveals the mechanism of ORC activation by the replication initiator Cdc6
por: Feng, Xiang, et al.
Publicado: (2021)